Stories

OHSU Is First in State to Implant New Heart Pump

October 21, 2009
Oregon Health & Science University is the first hospital in the state to implant the HeartMate II, a new left ventricular assist device (LVAD) designed to dramatically improve survival and quality of life in patients with end-stage heart failure. The ...

OHSU Hospital Gains Reaccreditation for its Chest Pain Center

August 18, 2009
Oregon Health & Science University Hospital has just completed the reaccreditation process for its Chest Pain Center. In 2006 OHSU became the first hospital in Oregon to achieve this status, and remains one of only two hospitals in Oregon accredited ...

OHSU in Nationwide Congenital Heart Disease Study

January 20, 2009
Oregon Health & Science University and 10 other academic medical centers have initiated a research study, funded by the National Institutes of Health, to determine reasons for gaps in the specialized care for patients with congenital heart disease ...

OHSU Cardiac ICU Wins National Recognition

December 30, 2008
TheCardiac and Surgical Intensive Care Unit (CSICU) of Oregon Health & Science University Healthcare has won the Beacon Award for Critical Care Excellence, which was given by the American Association of Critical-Care Nurses (AACN) in recognition of ...

Heading Circulatory Disease Off at the Pass

July 17, 2008
Researchers at Oregon Health & Science University have devised an ultrasound imaging technique that picks up subtle early evidence of peripheral arterial disease (PAD) that current conventional tests miss. The test, if approved for clinical use, could ...

Red Cross Recognizes OHSU 'Heroes'

March 11, 2008
Three Oregon Health & Science University physicians have been honored for the part they played in saving Kathy Ryan, the 66-year-old Portland woman who collapsed last August near Mist, Ore., during the Hood-to-Coast Relay. She was revived by two ...

Key Found to Breakthrough Drug for Clot Victims

March 10, 2008
OHSU, Washington University researchers have identified the mechanism that makes a bioengineered enzyme function efficiently, opening the way to clinical development of the first safe clot busting agent for treating heart attacks and strokes.

OHSU’s 500th Heart Recipient Spreads Her Wings

February 19, 2008
Monica Davenport has a life again after nearly a decade with a failing heart that imposed increasingly oppressive limits. She had to retire from her secretarial job in 2000 because she grew too weak even to carry file folders. As time wore on she was ...
See more stories